Combining ATAC-Seq, CUT&Tag, RNA-seq, and CyTOF, we demonstrate that targeting of RSK1 suppresses NFκB activation and diminishes pro-inflammatory mediators including TNF associated with MPN disease severity and transformation.
Combining ATAC-Seq, CUT&Tag, RNA-seq, and CyTOF, we demonstrate that targeting of RSK1 suppresses NFκB activation and diminishes pro-inflammatory mediators including TNF associated with MPN disease severity and transformation.
🏃🏃♀️🏃♂️Jog/run/sprint (don’t walk) to the poster walk at 11:15am featuring Molly’s poster.
And come to the poster session this evening (#1169)! 😁
@ash-hematology.bsky.social
🏃🏃♀️🏃♂️Jog/run/sprint (don’t walk) to the poster walk at 11:15am featuring Molly’s poster.
And come to the poster session this evening (#1169)! 😁
@ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
@ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
@ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
tinyurl.com/mpn-with-dr-oh
tinyurl.com/mpn-with-dr-oh